In February 2009, the UK government's Advisory Council on the Misuse of Drugs (ACMD) published a review of MDMA (ecstasy) which recommended a reclassification from the highest class A to the ‘intermediate category’ class B, on the basis of a review of recent scientific research. This became a matter of news attention alongside a recent journal article by Professor David Nutt, the chairman of...